ArticleSleep2026
The Respiration-Limb Coactivation Index (RLCI): A Continuous Signal-Based Biomarker for Stratifying Cardiovascular Disease Risk in a Cross-Sectional Sleep Cohort.
Article in Sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
STUDY
objectivesConventional respiratory-related limb movement (RRLM) metrics rely on event definitions and overlap rules that miss continuous respiratory-motor coupling intensity. We developed the respiration-limb coactivation index (RLCI), an algorithmic continuous biomarker, and evaluated associations with cardiovascular disease (CVD).
methodsIn Human Sleep Project polysomnography, RLCI was computed in S0001 (N = 20 737) as the interaction between respiratory-flow recovery and phasic leg-EMG envelope. The locked S0001 pipeline, without parameter tuning, was applied to two independent HSP centers (I0004, I0006). Prevalent coronary heart disease (CHD), cerebrovascular disease (CER), and peripheral vascular disease (PVD) associations were assessed by multivariable logistic regression with stage-restricted comparisons against LMI, PLMI, and RRLMI and signal-processing sensitivity analyses.
resultsAfter covariate adjustment, whole-night RRLMI was not significant for CHD or CER, whereas RLCI metrics, especially in N1 and first-half sleep, remained associated with CER and PVD. RLC N1 showed the strongest CER association (per-1-SD OR 1.11, 95% CI 1.06-1.15), and RLC FirstHalf was associated with PVD (OR 1.07, 95% CI 1.03-1.11). Stage-restricted RRLMI_N1 was significant for all four outcomes, supporting stage-matched benchmarking. Mutual adjustment suggested complementary RLCI information for CER and PVD, while conventional N1 respiratory-related movements better captured CHD. Findings were stable in sensitivity analyses and external validation.
conclusionsRLCI associations with CER and PVD suggest respiratory-linked motor coactivation captures autonomic surges distinct from cumulative hypoxia or sleep fragmentation and may complement AHI-based cardiovascular risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.